Clinical trial · Observational
Connecting Audio and Radio Sensing Systems to Improve Care at Home
Development and Pilot Testing of AURA
NCT05344950CI-TRIAL-00080612AURAcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to assess the usability of the innovative Audio + Radio (AURA) system in enhancing personalized supportive care for cancer patients and caregivers during the post-ostomy care transition by collecting information on patient's daily activities and answers to survey questionnaire, and enabling access to this information through a voice assistant device.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
| Uterine Cancer | Malignant Uterine Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Audio + Radio (AURA) | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- AURA
- description
- In addition to usual care, participants assigned to this arm will have access to our Audio + Radio (AURA) system.
- interventionNames
- Behavioral: Audio + Radio (AURA)
Primary outcomes (2)
- measure
- Satisfaction with the AURA system
- timeFrame
- 1-month followup survey
- description
- Satisfaction with the AURA system will be assessed by the 9-item Participant Satisfaction Scale measuring the level of program satisfaction ranging from 1=not satisfied to 5=extremely satisfied. Higher total score indicates greater program satisfaction.
- measure
- Perceived ease of use of the PRISMS program
- timeFrame
- 1-month followup survey
- description
- Perceived ease of use of the AURA system will be assessed by the 23-item Usability Scale measuring the ease of use in three aspects: general, content, and navigation. The scales range from 1=strongly disagree to 5=strongly agree. Higher total score indicates greater ease of use.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 99 Years
Show eligibility criteria text
Inclusion Criteria Phase I: The investigators will only be recruiting patients for this phase Patients must: * have been surgically treated for colorectal or bladder cancer with curative intent; * have had an ostomy with curative intent for at least 90 days; * be able to read and speak English; * be 18 years or older; Phase II: The investigators will be recruiting patients and caregivers as a dyad for this phase * Patients must: * have been surgically treated for colorectal or bladder cancer with curative intent; * be within one month of hospital discharge of a newly created ostomy with curative intent; * be able to read and speak English; * be 18 years or older; * have a caregiver who is willing to participate in the study; * Caregivers must: * be 18 years or older; * be able to read and speak English; * be identified as the primary caregiver by the patient; * have not themselves been diagnosed with cancer or received cancer treatment during the study (to ensure that patients and caregivers focus their efforts on care of the patient). Exclusion Criteria Patients and their caregivers will be excluded if they: * are unable to read, speak, or understand English; * have more than one type of ostomy; * have other cancer diagnosis (excluding non-melanomatous skin cancer); or * have cognitive impairment (assessed by the Short Portable Mental Status Questionnaire).
References
Publications (0)
Data not yet available
No reference posted for this study.